Status:
COMPLETED
ED50 and ED95 of Isobaric Bupivacaine for Post-Partum Bilateral Tubal Ligation
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Anesthesia, Local
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Spinal anesthesia is one of the preferred anesthetic techniques for post-partum bilateral tubal ligation (PBTL). Bupivacaine is the most commonly used local anesthetic for neuraxial anesthesia for pos...
Detailed Description
This prospective study proposes to enroll 40 post-partum women who are undergoing elective post-partum bilateral tubal ligation. The patient will be positioned sitting, and combined spinal anesthesia ...
Eligibility Criteria
Inclusion
- Age 18 and older
- Patients undergoing elective post-partum bilateral tubal ligation after vaginal delivery
- Patients receiving spinal epidural anesthesia with combination of bupivacaine and fentanyl
Exclusion
- American Society of Anesthesiologists physical status score \>3,
- Contraindications to neuraxial analgesia
- Patients in whom a combined spinal epidural cannot be performed
- Body mass index \>40 kg/m2
- Allergy or hypersensitivity to local anesthetics and fentanyl
- Severe liver, kidney or respiratory disease.
- Inability to understand the study protocol
- Refusal to provide written consent
Key Trial Info
Start Date :
February 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2020
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03779568
Start Date
February 25 2019
End Date
April 9 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkland Hospital
Dallas, Texas, United States, 75235